Replicating, tumor selective viruses are being tested as potential treatments for human cancers. Hypoxia is a pathophysiological cancer condition that alters the lytic potential of the replication-competent adenovirus serotype 5 (Ad5) virus by a mechanism independent of receptor l evels or internalization rates. We extend these initial studies to examine the potential effects of hypoxia on the group B adenoviruses (Ads), adenovirus type 3 (Ad3) (group B1) and adenovirus type 11p (Ad11p) (group B2).
Human adenovirus serotype 5 (Ad5) has been the traditional basis for Ad-based oncolytic viruses. [1] [2] [3] [4] [5] However, owing to the high prevalence of neutralizing antibodies against Ad5 [6] [7] [8] and the absence or limited expression of the attachment receptor for the virus (the coxsackievirus and adenovirus receptor, CAR) on potential target cells (including ovarian tumor cell lines, advanced prostate cancer, tumor tissue in squamous cell carcinoma of the head and neck), [9] [10] [11] [12] [13] the use of CARdependent adenoviruses as optimal backbones for oncolytic Ads is questionable. To address some of the challenges associated with the traditional group C Ads, several groups have investigated the development of vectors derived from the group B Ads. [14] [15] [16] [17] [18] [19] Group B Ads employ at least two receptors that are distinctly different from CAR. [20] [21] [22] Adenovirus type 3 and type 11p belong to subgroup B1 and B2 Ads, respectively, both of which use CD46 as a receptor for viral infection. 23, 24 In contrast to CAR expression, CD46 is overexpressed on a variety of hematological cancers and solid tumors. 25 In addition, serology testing for some of the group B viruses has demonstrated low or no detectable antibody titers with no cross-reactivity with Ad5.
14 This suggests that the Group B Ads may be effective viruses that overcome some of the limitations associated with the traditional group C Ad5-based virus.
Hypoxia (1% pO 2 ) is a pathophysical condition found in many diseases, such as cancer and ischemia. Previously, we and others evaluated the hypoxic effect on group C serotype, Ad5. 26, 27 Under 1% pO 2 , Ad5 replication and Ad5-specific cytolysis is attenuated 27 and suggests that Ad5-based oncolytic viruses need to be modified in order to be an effective cancer therapy. Using the same approaches, we studied the effect of hypoxia on the attachment, internalization and lytic function of group B1 (Ad3) and B2 (Ad11p) Ads.
Four cell lines were examined for surface expression of CD46 by flow cytometry under normoxic (20% pO 2 ) and hypoxic (1% pO 2 ) conditions ( Figure 1 ). DLD1 tumor cells expressed the highest level of CD46, whereas CD46 on the surface of Colo320DM cells is the lowest. The levels of CD46 in HT29 and HUVEC cells are intermediate. Under hypoxic conditions, CD46 levels in these cells were not altered when compared to CD46 levels seen in cells cultured under normoxic conditions. However, additional receptors have been reported for the group B2 viruses, 28 and viral uptake for group B viruses may also be affected by integrin-mediated internalization in a fashion similar to Ad5. 29 Therefore, we studied physical uptake of group B Ads by using a PCR-based method as previously described. 27 Cells were grown under hypoxic or normoxic conditions and infected with the group B Ads at 500 viral particles (vp)/cell for 4 h. Viral DNA was quantified by Taqman Q-PCR normalized to human genomic DNA. Colo320DM was used as a negative control, as it expresses very low levels of CD46 (Figure 1 ). Our data demonstrate that attachment is relatively equivalent between the group B Ads Ad3 or Ad11p and that this was not significantly altered by hypoxia (Figure 2a) . Interestingly, the attachment of Ad3, but not of Ad11p, more closely mirrored the pattern of CD46 surface expression. This suggests that CD46 is probably the main attachment receptor for Ad3 in the tested cell lines, whereas another receptor could contribute to Ad11p attachment in HT29 and HUVEC cells. In agreement with our observation, group B1 Ads (Ad3 and Ad7) and group B2 Ads (Ad11p and Ad35) share a common receptor sBAR (likely CD46), whereas sB2AR is exclusively used by group B2 Ads for uptake. 28 However, internalization of group B Ad was Figure 1 CD46 expression is not affected by hypoxic treatment. Cells were grown under hypoxic (1% pO 2 ) or normoxic (20% pO 2 ) conditions for 18 h and detached by cell dissociation buffer. 27 One million cells were labeled with mouse anti-CD46E4.3-FITC (RDI, Flanders, NJ, USA) or mouse IgG2a-FITC (Sigma, St Louis, MO, USA) on ice for 1 h. Cells were washed, fixed and analyzed by FACS scan. 27 The mean fluorescent intensity (MFI) is normalized to the isotype control and represents the CD46 cell surface expression level. Data are shown as mean7s.d. of three independent experiments.
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Ad11p Attachment Ad11p Uptake Figure 2 Ad3/Ad11p cellular attachment and uptake is not altered by hypoxia. Cells were pretreated and maintained in normoxic or hypoxic conditions throughout the infection. Cells were infected with Ad3/Ad11p 500 vp/cell at 41C to determine attachment, or at 371C for 3 h to determine viral internalization. The infected cells were washed with PBS and total DNA was prepared using the DNeasy kit (Qiagen, Valencia, CA,USA). Ad3/Ad11p Hexon and genomic b-actin DNA levels were quantified by real-time PCR. 27 The Ad3 Hexon primers and probe were Ad3Hexon2669F (CCCATGCGCTGGACATG), Ad3Hexon2737R (CGAAAAGAAGATAAAGCAGGGTG) and Ad3Hexon2688P (6FAM-TTTTGAGGTGGATCCCATGGATGAGC-TAMRA). The Ad11p Hexon primers and probe were ColoAd1Hexon34F (TACATGCA CATCGCCGGA), ColoAd1Hexon98R (CGGGCGAACTGCACCA) and ColoAd1Hexon-P (6FAM-CCGGACTCAGGTACTCCGAAGCATCCT-TAMRA). A b-actin primer/probe set for human genomic DNA was purchased from Applied Biosystems (Foster City, CA, USA). Purified Ad3 and Ad11p DNA or human genomic DNA (Applied Biosystems) was used as a standard. The virus uptake is represented by the ratio of Hexon to Actin (V ¼ Hexon/actin). The Hexon/actin ratio at 41C represents the attachment of virus particle (a). The internalized virus is quantified by subtracting the ratio at 41C from that at 371C (V37-V4) (b). Data represents the mean of two independent experiments. Figure 3 Ad3/Ad11p replication under hypoxic conditions. The indicated hypoxic or normoxic cells were plated and cultured for 18 h followed by infection with Ad3 or Ad11p at 500 vp/cell for 3 days. The infected cells and medium were harvested and subjected to a plaque assay 27 for quantitation of infectious virus. The virus titer is represented as plaque-formation units/ml (PFU/ml). The data represent three independent experiments. (Figure 2b ). These studies suggest that Ad11p uses an alternative attachment mechanism potentially associated with an alternative receptor, but that hypoxia does not significantly affect the uptake of group B1 Ad3 relative to group B2 Ad11p in the tested cells. Consequently, our studies suggest that Ad3/Ad11p should work effectively as a non-replicating gene delivery vector for cancer.
Effect of hypoxia on adenovirus
To be effective, replicating oncolytic Ads must selectively infect and kill cancer cells, replicating and spreading to neighboring tumor tissues in a continuous fashion until the tumor mass is eradicated. Therefore, we analyzed Ad replication under both normoxic and hypoxic conditions. Briefly, cells were infected with Ad3/Ad11p at 500 vp/cell and incubated for 3 days at which point cells and supernatant were collected. Total viral particles from the infected cells and culture medium were titered by a plaque-forming unit assay. On performing this assay, we found that group B Ads were efficiently replicated in DLD1, HT-29 and HUVEC cells ( Figure 3 ) and, as expected, there was no viral replication in Colo320DM cells under hypoxic or normoxic conditions (data not shown), given the low levels of CD46 expression (Figure 1, data not shown) . In contrast to the hypoxic attenuation of Ad5, 27 group B Ad replication was not significantly altered in most cells tested, with the exception of Ad11p replication in HT29, which was attenuated 10-fold under hypoxic conditions (Figure 3 ). Our data suggest that hypoxia may affect group B Ad replication in a cell-specific manner.
As a cancer treatment, cell lysis and spread of the progeny oncolytic virus is needed. By monitoring Ad3/Ad11p-specific cytolysis is delayed by hypoxic treatment. Cells were pretreated under hypoxic (1% pO 2 ) or normoxic (20% pO 2 ) conditions for at least 18 h, then infected with Ad3 (a) or Ad11p (b) at 500 vp/cell for up to 8 days under the same oxygen tension. The cell viability was assayed using MTS reagents at 0, 1, 2, 3, 6 and 7 days post infection at 371C with 5% CO 2 for 2 h. Viable cells were determined as a percentage of the noninfected controls. 27 Each assay point was tested in quadruplet. Similar results were generated from two independent experiments.
Effect of hypoxia on adenovirus BH Shen et al infected cell viability, we can analyze Ad-specific cytolysis under both hypoxic and normoxic conditions. Briefly, cells grown under either normoxic or hypoxic conditions were infected with Ad3/Ad11p at 500 vp/cell for up to 8 days. Each day, viable cells were quantitated by MTS assay (Promega), as described previously. 27 In agreement with data on viral replication, cell lysis occurred in DLD1 and HT29 under normoxic conditions, whereas while Colo320DM were resistant to Ad3/ Ad11p-specific cytolysis (Figure 4) . Within an 8-day window post infection, the cytolysis of DLD1, HT29 and HUVEC cells was delayed to different degrees under hypoxic treatments (Figure 4) . Interestingly, B20% of cell death of DLD1 was observed 1 day post infection, and the hypoxic delay in cytolysis was the least among the higher CD46-expressing cells (see Figure 1 ). Our data demonstrate that group B Ad-specific cytolysis is attenuated under hypoxic conditions in a cell-specific manner.
Previously, we observed similar hypoxic effects on Ad5 infection, and this correlated with decreased E1A protein and G1 cell cycle arrest. As antibody to group B E1A protein is not available, we could not evaluate E1A protein level and whether the same mechanism applies to the group B viruses. However, as hypoxia delayed cytolysis but did not significantly impact viral replication, we asked whether viral release and/or lysis of the infected cell were altered by hypoxic treatments. To test this, we measured viral particles released into the culture supernatant versus virus retained in the cells at a given time in the viral infection to try to quantify the effective release of virus during the viral infection. We included group C Ad, Ad5, to identify whether there were significant differences in viral release between group B and C adenoviruses under hypoxic conditions. As seen in Figure 5 , virus release was attenuated for all viruses examined. This work and our previous work 27 demonstrate that hypoxia attenuates the replication of group C Ad and the release of both group C and group B adenoviruses. This suggests that different strategies might be necessary to modify different serotypes of Ad as therapeutic reagents for cancer, especially for hypoxic regions of solid tumors. Thus, it is not clear whether current approaches targeted at ensuring expression of the critical E1A protein will be sufficient to address this issue. [30] [31] [32] In summary, our study on group B Ads demonstrates that hypoxia does not alter receptormediated viral uptake, but it can change viral replication and cytolysis in a viral-and cell-specific manner. Therefore, it would be interesting to know whether the viral release is the only limiting factor for group B Ad under hypoxia, and whether the cytolysis machinery is directly affected by hypoxia. We speculate that as the adenovirus life cycle is better understood in the context of the infected hypoxic cell, improvements can and will be made to more effectively treat hypoxic regions of human solid tumors. Figure 5 The release of group B and group C Ad is attenuated under hypoxic conditions. The indicated hypoxic or normoxic HT29 cells were plated and cultured for 18 h followed by infection with Ad3, Ad11p or Ad5 at 500 vp/cell for 5 days. The infected cells and supernatant were harvested separately and subjected to a plaque assay 31 for quantitation of infectious virus. The percentage of total burst for the supernatant and cell pellet was calculated as (viruses in supernatant)/(viruses in supernatant+viruses in cell pellet), respectively. Each assay point was tested in triplicate.
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